• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然存在的生物活性物质作为抗病毒剂:重点关注冠状病毒感染

Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.

作者信息

Ayatollahi Seyed Abdulmajid, Sharifi-Rad Javad, Tsouh Fokou Patrick Valere, Mahady Gail B, Ansar Rasul Suleria Hafiz, Krishna Kapuganti Shivani, Gadhave Kundlik, Giri Rajanish, Garg Neha, Sharma Rohit, Ribeiro Daniel, Rodrigues Célia F, Reiner Željko, Taheri Yasaman, Cruz-Martins Natália

机构信息

Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Pharmacognosy and Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Front Pharmacol. 2021 Jun 29;12:575877. doi: 10.3389/fphar.2021.575877. eCollection 2021.

DOI:10.3389/fphar.2021.575877
PMID:34267652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8277242/
Abstract

The current coronavirus disease (COVID-19) outbreak is a significant threat to human health and the worldwide economy. Coronaviruses cause a variety of diseases, such as pneumonia-like upper respiratory tract illnesses, gastroenteritis, encephalitis, multiple organ failure involving lungs and kidneys which might cause death. Since the pandemic started there have been more than 107 million COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ∼2.4 million deaths globally. SARS-CoV-2 is easily transmitted from person-to-person and has spread quickly across all continents. With the continued increase in morbidity and mortality caused by COVID-19, and the damage to the global economy, there is an urgent need for effective prevention and treatment strategies. The advent of safe and effective vaccines has been a significant step forward in the battle against COVID-19, however treatment of the symptoms associated with the disease still requires new anti-viral and anti-inflammatory drug therapies. To this end, scientists have been investigating available natural products that may be effective against SARS-CoV-2, with some products showing promise in fighting several viral infections. Since many natural products are dietary components or are prepared as dietary supplements people tend to consider them safer than synthetic drugs. For example, Traditional Chinese Medicines have been effectively utilized to treat SARS-CoV-2 infected patients with promising results. In this review, we summarize the current knowledge of COVID-19 therapies and the therapeutic potential of medicinal plant extracts and natural compounds for the treatment of several viral infections, with special emphasis on SARS-CoV-2 infection. Realistic strategies that can be employed for the effective use of bioactive compounds for anti-SARS-CoV-2 research are also provided.

摘要

当前的冠状病毒病(COVID-19)疫情对人类健康和全球经济构成重大威胁。冠状病毒可引发多种疾病,如类似肺炎的上呼吸道疾病、肠胃炎、脑炎以及涉及肺部和肾脏的多器官衰竭,这些情况可能导致死亡。自疫情爆发以来,全球由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的COVID-19感染病例已超过1.07亿例,死亡人数约为240万。SARS-CoV-2易于人际传播,已迅速蔓延至各大洲。随着COVID-19导致的发病率和死亡率持续上升,以及对全球经济的破坏,迫切需要有效的预防和治疗策略。安全有效的疫苗的出现是抗击COVID-19的重要一步,然而,对该疾病相关症状的治疗仍需要新的抗病毒和抗炎药物疗法。为此,科学家们一直在研究可能对SARS-CoV-2有效的天然产物,一些产物在对抗多种病毒感染方面显示出前景。由于许多天然产物是饮食成分或被制成膳食补充剂,人们往往认为它们比合成药物更安全。例如,中药已被有效用于治疗SARS-CoV-2感染患者并取得了有希望的结果。在本综述中,我们总结了当前关于COVID-19治疗方法的知识以及药用植物提取物和天然化合物对几种病毒感染的治疗潜力,特别强调了SARS-CoV-2感染。还提供了可用于有效利用生物活性化合物进行抗SARS-CoV-2研究的实际策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b341/8277242/703cec68abc2/fphar-12-575877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b341/8277242/25f9e9f15470/fphar-12-575877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b341/8277242/703cec68abc2/fphar-12-575877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b341/8277242/25f9e9f15470/fphar-12-575877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b341/8277242/703cec68abc2/fphar-12-575877-g002.jpg

相似文献

1
Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.天然存在的生物活性物质作为抗病毒剂:重点关注冠状病毒感染
Front Pharmacol. 2021 Jun 29;12:575877. doi: 10.3389/fphar.2021.575877. eCollection 2021.
2
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
3
Current Strategies of Antiviral Drug Discovery for COVID-19.新型冠状病毒肺炎抗病毒药物研发的当前策略
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
4
Traditional herbs against COVID-19: back to old weapons to combat the new pandemic.传统草药防治 COVID-19:用老武器对抗新疫情。
Eur J Med Res. 2022 Sep 26;27(1):186. doi: 10.1186/s40001-022-00818-5.
5
Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).单克隆抗体治疗作为潜在治疗干预手段用于新型冠状病毒病-19(COVID-19)的观点。
Asian Pac J Allergy Immunol. 2020 Mar;38(1):10-18. doi: 10.12932/AP-200220-0773.
6
Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.新型冠状病毒病(COVID-19)背景下的上呼吸道病毒感染:鼻科医生的入门知识。
Am J Rhinol Allergy. 2021 Jan;35(1):122-131. doi: 10.1177/1945892420947929. Epub 2020 Aug 6.
7
Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.植物化学制剂对 SARS-CoV 的作用及其在 COVID-19 中应用的选择:一个小型综述。
Curr Pharm Biotechnol. 2021;22(4):444-450. doi: 10.2174/1389201021666200703201458.
8
Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.草药药物治疗 COVID-19:范围综述。
Curr Pharm Des. 2021 Oct 5;27(31):3389-3398. doi: 10.2174/1381612827666210705163807.
9
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
10
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.

引用本文的文献

1
In silico network pharmacology study on Glycyrrhiza glabra: Analyzing the immune-boosting phytochemical properties of Siddha medicinal plant against COVID-19.甘草的网络药理学研究:分析 Siddha 药用植物对 COVID-19 的免疫增强植物化学特性。
Adv Protein Chem Struct Biol. 2024;138:233-255. doi: 10.1016/bs.apcsb.2023.04.003. Epub 2023 Jun 17.
2
Plausibility of natural immunomodulators in the treatment of COVID-19-A comprehensive analysis and future recommendations.天然免疫调节剂治疗COVID-19的合理性——全面分析与未来建议
Heliyon. 2023 Jun;9(6):e17478. doi: 10.1016/j.heliyon.2023.e17478. Epub 2023 Jun 21.
3

本文引用的文献

1
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和有效性:俄罗斯一项随机对照 3 期临床试验的中期分析。
Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2.
2
Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease.新型冠状病毒肺炎候选疫苗的最新研究进展综述
Infect Drug Resist. 2021 Jan 19;14:151-161. doi: 10.2147/IDR.S288877. eCollection 2021.
3
Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle.
Natural Products and Derivatives as Potential Inhibitors: A Comprehensive Review.
天然产物及其衍生物作为潜在抑制剂:全面综述。
Viruses. 2023 May 20;15(5):1211. doi: 10.3390/v15051211.
4
The use of the nutritional supplements during the covid-19 outbreak in Saudi Arabia: A cross-sectional study.沙特阿拉伯在 COVID-19 疫情期间营养补充剂的使用情况:一项横断面研究。
Complement Ther Med. 2023 Mar;72:102917. doi: 10.1016/j.ctim.2023.102917. Epub 2023 Jan 9.
5
Therapeutic Applications of Fucoidans and their Potential to Act Against COVID-19.岩藻多糖的治疗应用及其对抗 COVID-19 的潜力。
Curr Pharm Des. 2022;28(46):3671-3676. doi: 10.2174/1381612829666221207093215.
6
Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences.甘草甜素作为对抗新型冠状病毒的一种有前景的克星:临床、实验及理论证据
J Mol Struct. 2023 Mar 5;1275:134642. doi: 10.1016/j.molstruc.2022.134642. Epub 2022 Nov 25.
7
The role of natural products from medicinal plants against COVID-19: traditional medicine practice in Tanzania.药用植物中的天然产物在抗击新冠病毒中的作用:坦桑尼亚的传统医学实践
Heliyon. 2022 Jun 15;8(6):e09739. doi: 10.1016/j.heliyon.2022.e09739. eCollection 2022 Jun.
8
Extra Virgin Olive Oil-Based Green Formulations With Promising Antimicrobial Activity Against Drug-Resistant Isolates.基于特级初榨橄榄油的绿色配方对耐药菌株具有有前景的抗菌活性。
Front Pharmacol. 2022 Apr 25;13:885735. doi: 10.3389/fphar.2022.885735. eCollection 2022.
9
Ayurvedic formulations: Potential COVID-19 therapeutics?阿育吠陀配方:潜在的新冠治疗方法?
Phytomed Plus. 2022 Aug;2(3):100286. doi: 10.1016/j.phyplu.2022.100286. Epub 2022 Apr 20.
10
Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal.盐酸米托蒽醌是一种经美国食品药品监督管理局(FDA)批准的药物,它与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核衣壳蛋白1(NSP1)的C末端结合。
RSC Adv. 2022 Feb 16;12(9):5648-5655. doi: 10.1039/d1ra07434b. eCollection 2022 Feb 10.
草药免疫增强剂:抗击大流行新冠病毒的重要战士。
Phytomedicine. 2021 May;85:153361. doi: 10.1016/j.phymed.2020.153361. Epub 2020 Oct 3.
4
COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?2019冠状病毒病:是否有证据支持使用草药作为辅助对症治疗?
Front Pharmacol. 2020 Sep 23;11:581840. doi: 10.3389/fphar.2020.581840. eCollection 2020.
5
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.两种配方的基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和免疫原性:来自俄罗斯的两项开放、非随机的 1/2 期研究。
Lancet. 2020 Sep 26;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3. Epub 2020 Sep 4.
6
Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds.罗卡酰胺和西维来司他:从抗肿瘤化合物到抗冠状病毒化合物的漫长故事。
Nat Prod Rep. 2021 Jan 1;38(1):18-23. doi: 10.1039/d0np00024h. Epub 2020 Jul 23.
7
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的疫苗全球竞赛及2019冠状病毒病大流行概况
Front Pharmacol. 2020 Jun 19;11:937. doi: 10.3389/fphar.2020.00937. eCollection 2020.
8
Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.植物化学制剂对 SARS-CoV 的作用及其在 COVID-19 中应用的选择:一个小型综述。
Curr Pharm Biotechnol. 2021;22(4):444-450. doi: 10.2174/1389201021666200703201458.
9
Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M enzyme through in silico approach.通过计算机模拟方法揭示抗 SARS-CoV-2 M 酶的具有抗病毒作用的植物化学成分
Life Sci. 2020 Aug 15;255:117831. doi: 10.1016/j.lfs.2020.117831. Epub 2020 May 22.
10
A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19).治疗药物和中草药抗 SARS-CoV-2(COVID-19)的综述。
Pharmacol Res. 2020 Aug;158:104929. doi: 10.1016/j.phrs.2020.104929. Epub 2020 May 20.